Literature DB >> 8923470

Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha.

B Zhang1, J Berger, E Hu, D Szalkowski, S White-Carrington, B M Spiegelman, D E Moller.   

Abstract

Recent studies indicate that a peroxisome proliferator-activated receptor, PPAR gamma, functions as an important adipocyte determination factor. In contrast, tumor necrosis factor-alpha (TNF alpha) inhibits adipogenesis, causes dedifferentiation of mature adipocytes, and reduces the expression of several adipocyte-specific genes. Here, we report that treatment of 3T3-L1 adipocytes with TNF alpha resulted in a time- and concentration-dependent decrease in PPAR gamma mRNA expression to the level detected in preadipocytes. PPAR gamma mRNA levels were reduced by 95% with 3 nM TNF alpha treatment for 24 h. Half-maximal effects were seen after 3 h treatment with 3 nM TNF alpha or with 50 pM TNF alpha (24-h exposure). Parallel reductions in PPAR gamma protein levels were also observed after treatment of 3T3-L1 adipocytes with TNF alpha. Using a ribonuclease protection assay, both alternatively spliced PPAR gamma isoforms (gamma 1 and gamma 2) were shown to be negatively regulated by TNF alpha. The down-regulation of PPAR gamma by TNF-alpha preceded the diminution in expression of other adipocyte-specific genes including CCAAT/enhancer binding protein and adipocyte fatty acid-binding protein (aP2). The effect of TNF alpha was specific for the gamma-isoform of PPARs, since the expression of PPAR delta mRNA was not affected by treatment with TNF alpha. Low level constitutive expression of PPAR gamma in 3T3-L1 adipocytes (at levels approximately 2- to 3-fold higher than in preadipocytes) partially blocked the inhibitory effect of TNF alpha on aP2 and adipsin expression. These findings support the following conclusions: 1) PPAR gamma expression is necessary for the maintenance of the adipocyte phenotype. 2) PPAR gamma, but not PPAR delta, expression is sufficient to attenuate TNF alpha-mediated effects on adipocyte phenotype. 3) Reduced PPAR gamma gene expression is likely to represent an important component of the mechanism by which TNF alpha exerts its antiadipogenic effects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923470     DOI: 10.1210/mend.10.11.8923470

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  74 in total

1.  The expression of adipogenic genes is decreased in obesity and diabetes mellitus.

Authors:  S T Nadler; J P Stoehr; K L Schueler; G Tanimoto; B S Yandell; A D Attie
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

2.  TGF-β mediates suppression of adipogenesis by estradiol through connective tissue growth factor induction.

Authors:  Ashok Kumar; Ming Ruan; Kari Clifton; Farhan Syed; Sundeep Khosla; Merry Jo Oursler
Journal:  Endocrinology       Date:  2011-11-08       Impact factor: 4.736

3.  Creeping fat in Crohn's disease: travelling in a creeper lane of research?

Authors:  A Schäffler; H Herfarth
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

4.  Regulation of nuclear translocation of HDAC3 by IkappaBalpha is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor gamma function.

Authors:  Zhanguo Gao; Qing He; Bailu Peng; Paul J Chiao; Jianping Ye
Journal:  J Biol Chem       Date:  2005-12-21       Impact factor: 5.157

Review 5.  Diet, fatty acids, and regulation of genes important for heart disease.

Authors:  John P Vanden Heuvel
Journal:  Curr Atheroscler Rep       Date:  2004-11       Impact factor: 5.113

6.  Uncoupling of inflammation and insulin resistance by NF-kappaB in transgenic mice through elevated energy expenditure.

Authors:  Tianyi Tang; Jin Zhang; Jun Yin; Jaroslaw Staszkiewicz; Barbara Gawronska-Kozak; Dae Young Jung; Hwi Jin Ko; Helena Ong; Jason K Kim; Randy Mynatt; Roy J Martin; Michael Keenan; Zhanguo Gao; Jianping Ye
Journal:  J Biol Chem       Date:  2009-12-17       Impact factor: 5.157

Review 7.  Mechanisms and metabolic implications of regional differences among fat depots.

Authors:  Tamara Tchkonia; Thomas Thomou; Yi Zhu; Iordanes Karagiannides; Charalabos Pothoulakis; Michael D Jensen; James L Kirkland
Journal:  Cell Metab       Date:  2013-04-11       Impact factor: 27.287

8.  Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway.

Authors:  Fiona C McGillicuddy; Elise H Chiquoine; Christine C Hinkle; Roy J Kim; Rachana Shah; Helen M Roche; Emer M Smyth; Muredach P Reilly
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

9.  Dysregulation of adipose glutathione peroxidase 3 in obesity contributes to local and systemic oxidative stress.

Authors:  Yun Sok Lee; A Young Kim; Jin Woo Choi; Min Kim; Shintaro Yasue; Hee Jung Son; Hiroaki Masuzaki; Kyong Soo Park; Jae Bum Kim
Journal:  Mol Endocrinol       Date:  2008-06-18

10.  Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.

Authors:  Guoqiang Jiang; Qing Dallas-Yang; Subarna Biswas; Zhihua Li; Bei B Zhang
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.